We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+8.12%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.92B
AUM Growth
+$54.6M
Cap. Flow
-$64.7M
Cap. Flow %
-3.37%
Top 10 Hldgs %
62.97%
Holding
44
New
Increased
8
Reduced
27
Closed
1

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$27.3M
2
ORCL icon
Oracle
ORCL
+$24.2M
3
RTX icon
RTX Corp
RTX
+$13.8M
4
CHRW icon
C.H. Robinson
CHRW
+$13.6M
5
NKE icon
Nike
NKE
+$9.82M

Sector Composition

Rank Sector Weight
1 Technology 22.46%
2 Healthcare 19.15%
3 Communication Services 16.12%
4 Consumer Staples 13.03%
5 Industrials 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.2T
$192M 9.98%
789,168
-42,277
-5% -$8.86M
MSFT icon
2
Microsoft
MSFT
$3.66T
$157M 8.18%
303,466
-14,613
-5% -$7.45M
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.09T
$135M 7.01%
268,008
+9,743
+4% +$4.72M
UL icon
4
Unilever
UL
$133B
$125M 6.5%
1,874,415
-43,003
-2% -$2.97M
DIS icon
5
Walt Disney
DIS
$178B
$117M 6.09%
1,021,831
-231,825
-18% -$27.3M
MDT icon
6
Medtronic
MDT
$116B
$112M 5.8%
1,170,942
-10,060
-0.9% -$925K
NVO
7
Novo Nordisk
NVO
$203B
$103M 5.35%
1,853,707
+341,030
+23% +$20M
ORCL icon
8
Oracle
ORCL
$442B
$100M 5.21%
355,900
-95,020
-21% -$24.2M
JNJ icon
9
Johnson & Johnson
JNJ
$629B
$90M 4.68%
485,620
-15,795
-3% -$2.71M
ASML icon
10
ASML
ASML
$695B
$71.5M 3.72%
73,830
-1,178
-2% -$926K
GD icon
11
General Dynamics
GD
$107B
$67.3M 3.5%
197,443
-8,645
-4% -$2.72M
RTX icon
12
RTX Corp
RTX
$300B
$55.1M 2.87%
329,256
-88,911
-21% -$13.8M
SBUX icon
13
Starbucks
SBUX
$124B
$52.6M 2.74%
621,908
+111,426
+22% +$9.97M
LLY icon
14
Eli Lilly
LLY
$1.09T
$46.9M 2.44%
61,459
+24,226
+65% +$18M
CHRW icon
15
C.H. Robinson
CHRW
$17.1B
$43.3M 2.25%
327,131
-116,180
-26% -$13.6M
V icon
16
Visa
V
$671B
$39.8M 2.07%
116,596
-5,046
-4% -$1.75M
HD icon
17
Home Depot
HD
$342B
$38.8M 2.02%
95,674
-3,931
-4% -$1.55M
ACN icon
18
Accenture
ACN
$110B
$36M 1.87%
146,168
-3,384
-2% -$882K
PG icon
19
Procter & Gamble
PG
$335B
$34.4M 1.79%
223,896
+15,253
+7% +$2.38M
DEO icon
20
Diageo
DEO
$52.2B
$32.1M 1.67%
336,548
-4,538
-1% -$476K
AAPL icon
21
Apple
AAPL
$4.41T
$31.7M 1.65%
124,335
-9,298
-7% -$2.1M
PEP icon
22
PepsiCo
PEP
$189B
$25.5M 1.33%
181,505
+14,070
+8% +$2.01M
BIL icon
23
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$22.5M 1.17%
245,697
-4,185
-2% -$383K
NVDA icon
24
NVIDIA
NVDA
$5.43T
$18.6M 0.97%
99,805
-2,356
-2% -$411K
HON icon
25
Honeywell
HON
$74.6B
$17.7M 0.92%
89,364
+27,906
+45% +$5.83M

Similar funds

Saratoga Research & Investment Management's Q3 2025 Portfolio in Review

As of Q3 2025, Saratoga Research & Investment Management held 44 positions worth $1.92B, up 2.9% from $1.87B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Saratoga Research & Investment Management withdrew a net $64.7M in Q3 2025, closing 1 position and reducing 27 holdings. Its most notable exit was Cognizant, an estimated $580K position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Saratoga Research & Investment Management added an estimated $20M to Novo Nordisk.

  • Saratoga Research & Investment Management added most to Novo Nordisk in Q3 2025, an estimated $20M increase.
  • Saratoga Research & Investment Management's biggest Q3 2025 reduction was Walt Disney, cutting an estimated $27.3M.
  • Saratoga Research & Investment Management fully exited Cognizant in Q3 2025, selling an estimated $580K.
  • Saratoga Research & Investment Management's ten largest holdings make up 63% of its $1.92B portfolio in Q3 2025.
  • Saratoga Research & Investment Management opened 0 new positions and closed 1 in Q3 2025.
  • Saratoga Research & Investment Management's portfolio value rose 2.9% quarter-over-quarter to $1.92B.

Based on Saratoga Research & Investment Management's 13F filing for Q3 2025, filed 17 Nov 2025.